Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

113.06
Delayed Data
As of Dec 08
 +0.40 / +0.36%
Today’s Change
93.05
Today|||52-Week Range
127.00
-5.59%
Year-to-Date
The 3 Best Biotech Stocks for 2017
Dec 08 / MotleyFool.com - Paid Partner Content
Acceleron, Celgene Seek to Replace Entrenched Anti-Anemia Drugs in MDS Treatment
Dec 04 / TheStreet.com - Paid Partner Content
I'm Buying Biotech on This Trump Scare
Dec 08 / TheStreet.com - Paid Partner Content
Why bluebird bio Shares Rallied 24.7% In November
Dec 03 / MotleyFool.com - Paid Partner Content
Stock Market News for December 08, 2016
Dec 08 / Zacks.com - Paid Partner Content
Adventures in CAR-T Racing: Crashes and Curves Edition
Dec 02 / MotleyFool.com - Paid Partner Content
Trump Warns Investors "I'm Going To Bring Down Drug Prices"
Dec 07 / MotleyFool.com - Paid Partner Content
bluebird Stock Up on Positive Interim Multiple Myeloma Data
Dec 02 / Zacks.com - Paid Partner Content
Why You Should Let Celgene Corporation Invest Your Money
Dec 07 / MotleyFool.com - Paid Partner Content
Here's Why Bluebird Bio (BLUE) is Rallying Today
Dec 01 / Zacks.com - Paid Partner Content
Dow, S&P 500 Trade at Session Highs in Broad Wall Street Rally
Dec 07 / TheStreet.com - Paid Partner Content
Why bluebird bio, Inc. Stock Is Soaring Today
Dec 01 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Actelion Remains in M&A Spotlight, ASH Data in Focus
Dec 07 / Zacks.com - Paid Partner Content
NVIDIA, Sotheby's Holdings, Celgene, Regeneron Pharmaceuticals and Sanofi highlighted...
Nov 30 / Zacks.com - Paid Partner Content
Juno Reports Positive Phase I Study Data on Lymphoma Drug
Dec 06 / Zacks.com - Paid Partner Content
Celgene vs. Regeneron: Which Stock is a Better Pick?
Nov 29 / Zacks.com - Paid Partner Content
3 Top Healthcare Stocks
Dec 06 / MotleyFool.com - Paid Partner Content
Celgene Stock Split: Is the Biotech Ready to Split Again?
Nov 28 / MotleyFool.com - Paid Partner Content
Acceleron, Celgene Present Myelodysplastic Syndromes Data
Dec 05 / Zacks.com - Paid Partner Content
Better Buy: Celgene Corporation vs. Merck & Co.
Nov 25 / MotleyFool.com - Paid Partner Content
Why Celgene Shares Jumped 13.9% In November
Dec 05 / MotleyFool.com - Paid Partner Content
Trump win sparks seismic shift in markets
Nov 15 / CNNMoney.com